Dear Label_Name,

Greetings! I hope you are well.

I am writing on behalf of an international publishing house, Science and Education Publishing, USA (http://www.sciepub.com).

Science and Education Publishing (SciEP) is a multidisciplinary open access publisher of Journals covering the fields of Science, Technology and Medicine. All SciEP publications are subject to high-quality peer review, editorial and production processes and are freely available online.

Welcome to the April, 2013 edition of SciEP newsletter, providing monthly summaries of articles on science & education related topics of interest to scientist and professionals. The mission of our journals is to provide an open access forum for publishing new findings on issues pertinent to scientific and academic field. We also invite you to submit original research papers, review articles, short reports, or case studies are considered for publication in our Multidisciplinary Journals.

American Journal of Public Health Research
DOI: 10.12691/ajphr-1-1-3

The Implementation of a Tele-Homecare System with Service Oriented Architecture and HL7 Message Transmission Standard
Ching-Sung Wang

American Journal of Medical and Biological Research
DOI: 10.12691/ajmbr-1-1-2

The Influence of Ethanol on Pyruvate Kinases Activity in Vivo, in Vitro, in Silico
Lelevich Sergey Vladimirovich, Khrustalev Vladislav Victorovich, Barkovsky Eugene Victorovich, Shedogubova Tatyana Aleksandrovna

American Journal of Medical Sciences and Medicine
DOI: 10.12691/ajmsm-1-1-1

Clinical and Histological Features in Wegener Granulomatosis
Li Cavoli Gioacchino, Passantino Rita, Bono Luisa, Tortorici Calogera, Ferrantelli Angelo, Giammarresi Carlo, Rotolo Ugo

American Journal of Infectious Diseases and Microbiology
DOI: 10.12691/ajidm-1-1-2

The Curse of Lymphatic Filariasis: Would the Continual Use of Diethylcarbamazine Eliminate this Scourge in Papua New Guinea?
Anne Lanham, Lillian Mwanri

We have released issues of some journals on February 2013.
American Journal of Public Health Research
American Journal of Medical Sciences and Medicine
American Journal of Medical and Biological Research
American Journal of Pharmacological Sciences
American Journal of Clinical Medicine Research
American Journal of Nursing Research
American Journal of Cancer Prevention
American Journal of Medicine Studies
American Journal of Infectious Diseases and Microbiology
American Journal of Cardiovascular Disease Research
American Journal of Biomedical Research
American Journal of Mechanical Engineering
American Journal of Microbiological Research
Journal of Preventive Medicine
American Journal of Food and Nutrition
American Journal of Hypertension Research
American Journal of Sports Science and Medicine
Journal of Cancer Research and Treatment
American Journal of Zoological Research
Journal of Biomedical Engineering and Technology
American Journal of Microbiological Research
Biomedical Science and Engineering

We are pleased to announce that submissions are now being accepted for peer review for all the journals across all our subject areas in SciEP.

Please submit your manuscript via our online submission system:
http://www.sciepub.com/author/signin

To unsubscribe from our mailing list, please click on the following link: unsubscribe

I am looking forward to hearing from you.

Kind regards,

David Rain
Email:join@sciepub.com
Science and Education Publishing (http://www.sciepub.com)

Benefits and Effectiveness of Using Paullinia cupana: A Review Article

Adele Salomão-Oliveira*, Emerson Silva Lima, Helyde Albuquerque Marinho, Rosany Piccolotto Carvalho

Multi-Institutional Post-Graduate Biotechnology Program, Universidade Federal do Amazonas (UFAM), Manaus, AM, Brazil

Abstract: Guarana is native to the Amazonian region of Brazil and, widely used in liquid preparations due to its stimulating effect, along with other therapeutic properties. Its chemical components, methylxanthines and condensed tannins, exhibiting a marked biological activity, may be found in commercially available powdered guarana brands at varying levels, possibly due to their provenance and drying processes. However, the chemical standardization of its extract maintains the same quantified content of active substances on each and every lot of extract produced, thus asssuring their quality and therapeutic efficacy. Consumption of guarana by the population should be controlled, since there is controversy as to its dosage and association with allopathic drugs, the interactions of which may result in increasing the therapeutic effect, reducing efficacy or even bringing about adverse reactions. However, the use of guarana in adequate concentrations may contribute to achieve therapeutic properties with less toxicity on account of it being some natural antioxidants source and considered one of the most important new substances directly used as effective medicinal agents.

Keywords: Paullinia cupana, guaraná, sapindaceae, Amazônia

Received July 07, 2018; Revised August 16, 2018; Accepted August 22, 2018

Citation: Adele Salomão-Oliveira, Emerson Silva Lima, Helyde Albuquerque Marinho, Rosany Piccolotto Carvalho, Benefits and Effectiveness of Using Paullinia cupana: A Review Article. Journal of Food and Nutrition Research, 6 (8). 497-503. January 2018. doi:10.12691/jfnr-6-8-2

1. Introduction

Paullinia cupana Kunth originates from the Amazon Basin, belongs to family Sapindaceae and is consumed on a global scale [1]. Historical data reveal that guaraná was already known by the Maués, Andirás and Marabitanas tribes of Amazonia, before the arrival of the Europeans, due to its stimulating [2], antidepressant [3] and diuretic [4] activities.

Large amounts of methylxanthines, including caffeine, theophylline and theobromine, in addition to saponins, polyphenols, and especially condensed tannins, are responsible for the benefits brought on to the population on account of being chemical substances bearing bioactive properties [5].

Therefore, the biologic activities of guarana possess therapeutic indications, to be investigated in the prevention treatment of diseases, with promising perspectives for producing novel phyto drugs.

2. Chemical Characteristics

Guarana seeds (Figure 1), source: Rebelo/INPA-Brazil, contain a high concentration of bioactive components, described in 1669, when their daily use by the indigenous peoples of the Amazon region, was observed.

Figure 1. Guaraná fruit

Among the main chemical constituents of guarana, methylxanthines, I- Caffeine (1,3,7-trimethylxanthine), II- Theophylline (1,3-dimethylxanthine) and III- Theobromine (3,7-dimethylxanthine) (Figure 2 & Figure 3) [90] and condensed tannins, are composed of interconnected monomeric units, the main ones of which being proanthocyanidin: catechin and epicatechin (flavan-3-ol), due to their antioxidant effect in the protection of atherosclerotic cardiovascular diseases and the process of carcinogenesis [6,7,8,9]. Phytochemical composition includes: xanthine: caffeine (1,3,7-trimethylxanthine) (2 to 7.5%), theobromine (0.02 to 0.03%) and theophylline (0.25%). In the essential oil, cyclic sesquiterpenes and cyclic monoterpenes were identified. Minerals were also identified: calcium (0.1%), phosphorus (0.3%), potassium (0.3%), magnesium (0.08%), iron (4.3 mg); flavonoids: catechol and epicatechol; tannins (8.5 to 25%) [2,9,10,11,12,13,14,15].

Figure 2. Guaraná-methylxanthines

Figure 3. Metlhylxanthines

3. Biological Activity

Several studies on the medicinal properties of guarana seeds have been carried out, especially in the last three decades, demonstrating the potential of the biological activities concentrated in guarana with its exceptional content of methylxanthines and proanthocyanidins [11]. Thus, the isolated substances have already been analyzed according to the studies described below (Table 1).

4. Bioactive Compound Contents

In the scientific literature, the data on the concentration of guarana powder are conflicting, depending on the region of planting and techniques used for its cultivation and drying processes. Studies have verified different levels of caffeine in marketed powdered Guarana brands, being outside the pharmacopoeia quality specifications. The caffeine content in the samples presented a great variability, in the range of 9.52 to 36.71 mg / g of powder. Due to this variation, the consumers of this product are liable to ingest uncontrolled doses, which may cause a health damage [44]. This demonstrates the need to implement quantitative techniques in the physical-chemical quality control of plant raw materials, in addition to the need to qualify suppliers by emphasizing the control in acquisition, storage and handling [45].

Under this context, studies will provide better definitions, showing guarana to bear a higher caffeine content than that of coffee seeds (7.59 mg caffeine / gram of guarana powder), verified in the studies [44], in threefold higher quantity, with a mean caffeine concentration of 20.68 mg / g (caffeine / gram of powder), and this difference can reach up to fourfold [46].

Technological alternatives are necessary in order to consume guarana since it tastes bitter and irritates the gastrointestinal tract. Short-term medicinal effects are commonly considered to result from caffeine and associated alkaloids high content as well as considerable amounts of tannins [4,47]. Thus, future research may show that various saponins also play an important role in pharmacology of the drug, particularly with regard to its long-term influence as a general and prophylactic toner.

Studies have noted that five minutes after consumption, caffeine can be detected throughout the human body, reaching its peak action after 30 minutes and lasting from four to six hours. Excessive consumption of caffeine-rich foods can cause unpleasant symptoms such as irritability, headaches, insomnia, diarrhea and tachycardia. Guarana should not be consumed by individuals, with a history of heart disease, hypertension, sensitive to caffeine use, and with gastrointestinal disorders (irritable bowel syndrome, colitis, diarrhea, gastritis). Eating more than 400mg per day can lead to so-called "caffeinism" the most common symptoms of which have shown to be anxiety, restlessness, irritability, tremors, appetite loss, muscle tension, insomnia, and heart palpitations. The safe dose of guarana powder has not been defined as of yet [44,48,49,50].

Conversely, effects can be described as increased alertness and reduced fatigue associated with improved performance of activities [3,18,27,44,51].

Studies have shown guarana concentration to be of critical importance for the cytotoxic activity of the compounds present in guarana. Low guarana concentrations have been shown to be harmless, whereas higher ones could be cytotoxic [33,52,53].

As to phenols, they are not considered to be toxic in normal amounts and conditions, except for polymeric phenols called tannins, which have the ability to complex and precipitate proteins from aqueous solutions [54]. When oxidized, tannins turn into quinones, which form covalent bonds with some functional groups of the proteins, mainly the cysteine and lysine ε-amino sulfide groups [55].

More specifically, tannins are high molecular weight compounds, containing enough phenolic hydroxyl groups, to allow the formation of stable cross-links with proteins [56]. They are present in a larger quantity in the foods normally consumed, in the composition of the dietary fiber fraction of different foods and may be considered indigestible or partially digestible [54,56,57,58,59].

Experimental evidence confirms previous observations that polyphenolic compounds significantly inhibit iron absorption, but the negative effect of tannin on iron absorption can be effectively prevented by simultaneous administration of ascorbic acid [60,61].

Table 1. Biological activity verified in the seed of P. cupana

However, no effect of tannins on calcium absorption was observed in rats [62]. For the authors, the explanation of the results may be due to the fact that tannins preferentially bind to the iron leaving the calcium free. With respect to calcium homeostasis, data compiled in a review indicate that caffeine is not detrimental to bone metabolism of individuals whose calcium intake is adequate to their daily metabolic needs [63].

Thus, moderate consumption of guarana (maximum 4.6mg/kg body weight/day) in healthy adults of reproductive age is not associated with adverse effects [64,65,66]. Therefore, it is important to carefully instruct the use of guarana to the population with prescription and guidelines [44,67,68,69].

5. Drug Interactions

The use of caffeine in the form of drugs, as for instance, in anti-flu drugs, and of a lot it in the composition of a variety of dietary supplements, is mainly used because of its high content [12,70,71].

Guarana potentiates the action of analgesics, antidepressant activity, and, consumed with anticoagulants can lead to inhibition of platelet aggregation, thus increasing the risk of bleeding [68].

Drug interactions are pharmacological responses, in which the effects of one or more medicinal products are altered by their concomitant administration. These interactions are both observed with synthesized chemicals (allopathic drugs), and those present in plants being used in home preparations and herbal medicines [72].

However, interactions with guarana may result in its therapeutic effect potentiation, efficacy reduction or the appearance of adverse reactions [72,73,74].

6. Use of Guarana in Allopathy

As a medicinal plant guarana holds an essential content of caffeine makes part of the pharmacopoeia of Brazil, [75] and several European countries, Mexico and the United States. "Guarana” is used in migraines as a sedative and tranquilizer, has shown to be an excellent in the convalescence of serious diseases; inestimable cardiovascular, exerting a generalized tonic action in the senile evolution. It regulates the cardiac energy, combats and prevents the passive congestions so peculiar and frequent in the aged “organs" [76]. Thus, treating the therapeutic value of this Sapindácea reveals that daily consumption has a neurostimulating effect [77]. Guarana is one of the most important and advantageous medicines of modern therapy, on account of properties. Its therapeutic value, evidenced in studies and trials, is increasing and, represents an important role of worldwide repercussion, in medicine [78]. The compendia and pharmacological catalogs clearly describe numerous and vast uses of guarana in the various formulas.

It can be observed that the therapeutic knowledge of guarana is ancient, and it was observed that in the Upper Amazon, the general use of chewing small fragments of guarana paste, can prevent one from feeling thirsty, hungry, and even physically and mentally fatigued, and able to work longer hours. And that the use of the guaraná paste this way leaves a bitter taste in the mouth, which can be sweetened by the ingestion of water [79].

A specified study has found guarana to act as a physiological functions stimulant and an excellent intestinal regulator [80]. Aiming at the development of its culture and use, they report its action as an aphrodisiac to be the most important one [4,47].

Due to being a source of bioactive substances with multifaceted activity, guarana is used in therapeutics to treat human diseases as well as to rise its effectiveness in acting as stimulants [20,32,81].

The interest in its consumption is due to its high content of caffeine and tannins [35], with antioxidant action in the promotion, prevention and recovery of health, in addition to other biological properties [82]. Thus, caffeine appears to have an effect on the control of the metastasis process [83] and the catechins associated with other derivative tannins present in guarana, such as epicatechin, ent-epicatechin and procyanidins B1, B2, B3, B4, A2 and C1 [5], have been contributing to the control of in vivo melanoma growth by reducing cell proliferation and increasing cell death through apoptosis, in addition to antiaging activity, and verified in this Amazonian fruit [34].

The studies on the antibacterial activity of guarana could justify some ethnopharmacological uses, such as against diarrhea and dysentery, since they demonstrate the strong activity of this plant against some pathogens of the digestive tract [12].

According to studies, the alcoholic extracts presented a higher antimicrobial activity against all the tested microorganisms than that of the aqueous extract in vitro, when found in three fungi transmitted by foods: Aspergillus niger, Trichoderma viride and Penicillium cyclopium and in three bacteria harmful to health: Escherichia coli, Pseudomonas fluorescens and Bacillus cereus [14]. However, the authors observed that in the aqueous extract, they presented higher amounts of caffeine and catechins, conferring greater antioxidant activity.

Due to the ongoing emergence of antibiotic-resistant strains, there is a continuing demand for new antibiotics. In many developing countries, about 80% of available medicines come from medicinal plants, and in developed countries plants are the raw material for processes that synthesize pure chemical derivatives [84].

Among the therapeutic effects of guarana, it it comes to cotribute in a beneficial and effective way when included in the development of new drugs in intermediate and final pharmaceutical forms, since it minimized side effects [85], when administered correctly, and is more more cost effective since it can be obtained from natural sources and does not need to be industrialized [86,87,88].

Complexes containing caffeine and catechins (and their dimers) may be responsible for antiplatelet aggregating activity in guarana seeds and may offer health benefits by lowering the risk of thrombosis and cardiovascular disease [89].

For decades, the phenolic compounds of guarana have been of interest for studies, due to their phytochemicals bearing beneficial effects on human health, able to stabilize free radicals, increasing antioxidant activity, among other biological and pharmacological effects. Therefore, recent studies have verified that guarana catechins are bioavailable and contribute to reduce the oxidative stress of clinically healthy individuals by the direct antioxidant action of the absorbed photochemistry and the positive regulation of enzymes, thus reinforcing the published research on the benefits to human health with the use of guarana [34].

7. Summary

The therapeutic properties of guarana are attributable to more than one potentially bioactive component. These include the relatively high levels of saponins, tannins, and caffeine contained in guarana extracts. The perspective of association with single or multiple vitamins and minerals deserves to be investigated in order to make part of new drugs. Thus, the relationship between the concentration of guarana bioactive compounds and their antioxidant capacity is associated with the therapy of diseases and beneficial effects for health. The study of the presence and concentration of these compounds in guaraná should be expanded, in order to allow a better evaluation of their effects, allowing a broader understanding that aims to contribute in several aspects regarding their use, such as: chemical composition, quality control, kind of extraction, therapeutic value, posology, pharmacological potential and association with allopathic drugs.

Acknowledgements

The authors are grateful to the Federal University of Amazonas.

Conflict of Interest

The authors declare no conflict of interest.

References

[1]   | Souza, V.C. and Lorenzi, H. Botânica Sistemática: guia ilustrado para identificação das famílias de angiospermas da flora brasileira, baseado em APG II, 2nd edition, New Odessa, Plantarum Institute, 2008.
[2]   | Espínola, E.B., Dias, R.F., Mattei, R. and Carlini, E.A., “Pharmacological activity of Guaraná (Paullinia cupana Mart.) in laboratory animals”, J Ethnopharmacol, 55(3). 223-229. 1997.

[3]  
Otobone, F.J., Sanches, A.C.C., Nagae, R., Martins, J.V.C., Obici, S., De Mello, J.C.P. and Audi, E.A., “Effect of crude extract and its semi purified constituents from guaraná seeds [Paullinia cupana var. sorbilis (Mart.) Ducke] on cognitive performance in Morris Water Maze in Rats”, Arch Biol Technol, 48(5). 723-728. 2005.

[4]   | Henman, A.R., “Guaraná (Paullinia cupana var. Sorbilis): Ecological and social perspectives on an economic plant of the central amazon basin”, J Ethnopharmacol, 6(3). 311-338. 1982.

[5]  
Yamaguti-Sasaki, E., Ito, L.A., Canteli, V.C., Ushirobira, T.M., Ueda-Nakamura, T., Dias Filho, B.P., Nakamura, C.V. and De Mello, J.C.P., “Capacidade antioxidante e prevenção in vitr da formação de placas dentárias por extratos e taninos condensados de Paullinia cupana”, Molecules, 12(8). 1950-1963. 2007.

[6]   | Hanasaki, Y., Ogawa, S. and Fukui, S., “The correlation betweeen active oxygens scavenging and antioxidative effects of flavonoids”, Free Radical Bio Med, 16(6). 845-850. 1997.
[7]   | Moraes, M.L., Micke, G.A., Fujiya, N.M. and Tavares, M.F.M., “Separação e análise de metilxantinas em extratos de guaraná e erva-mate por eletroforese capilar”, Rev Analytica, 5(5). 44-50. 2003.
[8]   | Heard, C.M., Johnson, S., Moss, G. and Thomas, C.P., “In vitro transdermal delivery of caffeine, theobromine, theophylline and catechin from extract of guarana, Paullinia cupana”, International Journal of Pharmaceutics, 317(1). 26-31. 2006.
[9]   | Ushirobira, T.M.A., Yamaguti, E., Uemura, L.M., Nakamura, C.V., Filho, B.P.D. and Mello, J.C.P., “Chemical and microbiological study of extract from seeds of guaraná (Paullinia cupana var. Sorbilis)”, Latin American Journal of Pharmacy, 26(1). 5-9. 2007.
[10]   | Revilla, J. Apontamentos para a cosmética amazônica, 2nd edition, Manaus: SEBRAE/INPA, 2002.
[11]   | Rates, S.M.K. Metilxantinas. In: Simões, C.M.O., Schenkel, E.P., Gosmann, G., Mello, J.C.P., Mentz, L.A. and Petrovick, P.R. Farmacognosia da planta ao medicamento, 5th edition, Porto Alegre: Editora da UFSC, 2004.
[12]   | Basile, A., Ferrara, G., Del Pezzo, M., Mele, G., Sorbo, S., Bassi, P. and Montesano, D. “Antibacterial and antioxidant activities of ethanol extract from Paullinia cupana Mart”, J. Ethnopharmacol, 102(1). 32-36. 2005.
[13]   | Heard, C.M., Johnson, S., Moss, G. and Thomas, C.P., “In vitro transdermal delivery of caffeine, theobromine, theophylline and catechin from extract of guarana, Paullinia cupana”, Int J Pharmac, 317(1). 26-31. 2006.
[14]   | Majhenič, L., Škerget, M. and Željko, Z.K., “Antioxidant and antimicrobial activity of guarana seed extracts”, Food Chemistry, 104(3). 1258-1268. 2007.
[15]   | Alonso, J. Tratado de fitofármacos y nutracéuticos, Corpus Editorial y Distribuidora. Argentina, 2007.
[16]   | Campos, A.R., Barros, A.I.S., Santos, F.A. and Rao, V.S.N., “Guarana (Paulinnia cupana Mart.) offers protection against gastric lesions induced by ethanol and indomethacin in rats”, Phytotherapy Research, 17(10).1199-1202.2003.
[17]   | Renner, B., Clarke, G., Grattan, T., Beisel, A., Mueller, C., Werner, U., Kobal, G. and Brune, K., “Caffeine accelerates absorption and enhances the analgesic effect of acetaminophen”, J Clin Pharmacol, 47(6). 715-726. 2007.
[18]   | Otobone, F.J., Sanches, A.C.C., Nagae, R., Martins, J.V.C., Sela, V.R., De Mello, J.C.P. and Audi, E.A., “A Effect of lyophilized extracts from guaraná seeds [Paullinia cupana var. sorbilis (Mart.) Ducke] on behavioral profiles in rats. Phitoterapy Research, 21(6). 531-535.2007.
[19]   | Roncon, C.M., De Almeida, C.B., Klein, T., Mello, J.C.P. and Audi, E.A. “Anxiolytic effects of a semipurified constituent of guaraná seeds on rats in the elevated T-maze test”, Planta Medica, 77(3). 236-241. 2011.
[20]   | Rangel, M.P., De Mello, J.C.P. and Audi, E.A. “Evaluation of neurotransmitters involved in the anxiolytic and panicolytic effect of the aqueous fraction of Paullinia cupana (guaraná) in elevated T maze”, Revista Brasileira de Farmacognosia, 23(2). 358-365. 2013.

[21]  
Fukumasu, H., Avanzo, J.L., Nagamine, M.K., Barbuto, J.Á., Rao, K.V. and Dagli, M.L.Z., “Paullinia cupana Mart. Var. Sorbilis, guarana, reduces cell proliferation and increases apoptosis of B16/F10 melanoma lung metastases in mice”, Brasilian Journal of Medical and Biological Reasearch, 41(4). 305-310. 2008.

[22]   | Andersen, T. and Fogh, J., “Weight loss and delayed gastric emptying following a South American herbal preparation in overweight patients”, J Hum Nutr Dietet, 14(3). 243-250. 2001.
[23]   | Lima, W.P., Carnevali, J.R.L.C., Eder, R., Rosa, L.F.B.P.C., Bacchi, E.M. and Seelaendera, M.C.L., “Lipid metabolismo in trained rats: Effect of guaraná (Paullinia cupana Mart.) supplementation”, Clinical Nutrition, 24(6).1019-1028.2005.
[24]   | Ribeiro, J.A. and Sebastião, A.M., “Caffeine and adenosine”, J Alzh Dis, 20(Suppl 1). S3-S15.2010.
[25]   | Dulloo, A.G., Geissler, C.A., Horton, T., Collins, A. and Miller, D.S., “Normal caffeine consumption: influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers”, Am J Clin Nutr, 49(1). 44–50. 1989.
[26]   | Boozer, C.N., Nasser, J.A., Heymsfield, S.B., Wang, V., Chen, G. and Solomon, J.L., “An herbal supplement containing Ma Huang-Guaraná for weight loss: a randomized, double-blind trial”, Int J Obes Relat Metab Disord, 25(3). 316-324. 2001.

[27]  
Kennedy, D.O., Haskell, C.F., Robertson, B., Reay, J., Brewster-Maund, C., Luedemann J., Maggini, S., Ruf, M., Zangara, A., Scholey, A.B., “Improved cognitive performance and mental fatigue following a multi-vitamin and mineral supplement with added guaraná (Paullinia cupana)”, Appetite, 50(2-3). 506-513. 2008.

[28]   | Campos, A.R., Barros, A.I.S., Albuquerque, F.A.A., Leal, L.K.A.M. and Rao, V.S.N., “Acute effects of Guarana (Paullinia cupana Mart.) on mouse behavior in forced swimming and open field tests”, Phytother Res, 19(5).441- 443. 2005.
[29]   | Ray, S., Phadke, S., Patel, C., Hackman, R.M. and Stohs, S., “Short-term and long-term in vivo exposure to an ephedra- and caffeine-containing metabolic nutrition system does not induce cardiotoxicity in B6C3F1 mice”, Archives of Toxicology, 79(6).330-340.2005.
[30]   | Tavares, C. and Sakata, R.K., “Caffeine in the Treatment of Pain”, Rev Bras Anestesiol, 62(3). 387-401. 2012.
[31]   | Peroutka, S., Lyon, J.A., Swarbrick, J., Lipton, R.B., Kolodner, K. and Goldstein, J., “Efficacy of diclofenac sodium softgel 100 mg with or without caffeine 100 mg in migraine without aura: a randomized, double-blind, crossover study”, Headache, 44(2). 136-141. 2004.
[32]   | Kuskoski, E.M., Roseane, F., García, A.A. and Troncoso, G.A.M., “Chemical and pharmacological properties of the fruit Guaraná (Paullinia cupana)”, Vitae, 12(2).45-52. 2005.
[33]   | Mattei, R., Dias, R.F., Espínola, E.B., Carlini, E.A. and Barros, S.B.M., “Guarana (Paullinia cupana): toxic behavioral effects in laboratory animals and antioxidant activity in vitro”, J Ethnopharmacol, 60(2).111-116. 1998.

[34]  
Yonekura, L., Martins, C.A., Sampaio, G.R., Monteiro, M.P., César, L.A.M., Mioto, B.M., Mori, C.S., Mendes, T.M.N., Ribeiro, M.L., Arçari, D.P. and Torres, E.A.F.S., “Bioavailability of catechins from guaraná (Paullinia cupana) and its effect on antioxidant enzymes and other oxidative stress markers in healthy human subjects”, Food & Function, 7(7). 2970-2978. 2016.

[35]   | Fukumasu, H., Avanzo, J.L., Heidor, R., Silva, T.C., Atroch, A., Moreno, F.S. and Dagli, M.L., “Efeitos protetores do guaraná (Paullinia cupana Mart. Var. Sorbilis) contra o dano do DNA induzido por DEN no fígado do mouse”, Food Chem Toxicol, 44(6). 862-867. 2006.
[36]   | Chung, K.T., Lu, Z. and Chou, M.W., “Mechanism of inhibition of tannic acid and related compounds on the growth of intestinal bacteria”, Food and Chemical Toxicology, 36(12). 1053-1060. 1998.
[37]   | Vankemmelbeke, M.N., Jones, G.C., Fowles, C., Ilic, M.Z., Handley, C.J., Day, A.J., Knight, C.G. , Mort, J.S. and Buttle, D.J., “Selective inhibition of ADAMTS-1, -4 and -5 by catechin gallate esters”, Eur J Biochem, 270(11). 2394-2403. 2003.

[38]  
Andriamanalijaona, R., Kypriotou, M., Bauge, C., Renard, E., Legendre, F., Raoudi, M., Boumediene, K., Gatto, H., Monginoux, P. and Pujol, J.P., “Comparative effects of 2 antioxidants, selenomethionine and epigallocatechin-gallate, on catabolic and anabolic gene expression of articular chondrocytes”, J Rheumatol, 32(10). 1958-1967. 2005.

[39]   | Singh, R., Ahmed, S., Malemud, C.J., Goldberg, V.M. and Haqqi, T.M., “Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes”, J Orthop Res, 21(1). 102-109. 2003.

[40]  
Lin, S.K., Chang, H.H., Chen, Y.J., Wang, C.C., Galson, D.L., Hong, C.Y. and Kok, S.H., “Epigallocatechin-3-gallate diminishes CCI2 expression in human osteoblastic cells via up-regulation of phosphatidylinositol 3-Kinase/Akt/Raf-1 interaction: a potential therapeutic benefit for arthritis”, Arthritis Rheum, 58(10). 3145-3156. 2008.

[41]   | Lee, J.H., Jin, H., Shim, H.E., Kim, H.N., Ha, H. and Lee, Z.H., “Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the NF-κB signal. Mol Pharmacol”, 77(1). 17-25.2010.
[42]   | Morinobu, A., Biao, W., Tanaka, S., Horiuchi, M., Jun, L., Tsuji, G., Sakai, Y., Kurosaka, M. and Kumagai S., “(-)-Epigallocatechin-3-gallate suppresses osteoclast differentiation and ameliorates experimental arthritis in mice”, Arthritis Rheum, 58(7). 2012-8. 2008.
[43]   | Ottaviani, J. I., Momma, T. Y., Heiss, C., Kwik-Uribe, C., Schroeter, H. and Keen, C. L., “The stereochemical configuration of flavanols influences the level and metabolism of flavanols in humans and their biological activity in vivo”, Free Radical Biology and Medicine, 50.(2). 237-244. 2010.
[44]   | Tfouni, S. A. V.; Camargo, M. C. R.; Vitorino, S. H. P.; Menegário, T. F. and Toledo, M. C. F., “Contribution of guaraná powder (Paullinia cupana) as a source of caffeine in the diet”, Revista de Nutrição, 20(1).63-68. 2007.
[45]   | Bara, M.T.F., Ribeiro, P.A.M., Arantes, M.C.B., Amorim, L.L.S.S. and Paula, J.R., “Determinação do teor de princípios ativos em matérias-primas vegetais”, Rev Bras Farmacogn, 16(2). 211-215. 2006.
[46]   | Pizza, C., Rastrelli, L., Totaro, K. and De Simone, F., Il Guaraná degli Indios Sateré-Maué. Istituto Italo-Latinoamericana, Rome: Serie Scienza. Paullinia cupana (guaraná) determinazione degli alcaloidi xantinici per la valutazione della qualitá di prodotti base di guaraná. 13-22. 1999.
[47]   | Smith, N. and Atroch, A.L., “Guaraná's Journey from Regional Tonic to Aphrodisiac and Global Energy Drink”, Evid Based Complement Alternat Med, 7(3). 279-282. 2010.
[48]   | Pittler, M.H., Schmidt, K. and Ernst, E., “Adverse events of herbal food supplements for body weight reduction: systematic review. The international Association for the Study of Obesity”, Obesity Reviews, 6(2). 93-111. 2005.
[49]   | Sharpe, P.A., Granner, M.L., Conway, J.M., Ainsworth, B.E. and Dobre, M., “Availability of weight-loss supplements: results of na audito f retail outlets in a southeastern city”, Journal of the American Dietetic Association, 106(12). 2045-2051. 2006.
[50]   | Babu, K.M., Church, R.J. and Lewander, W., “Energy Drinks: The New Eye-Opener For Adolescents”, Clin Ped Emerg Méd, 9(1). 35-42, 2008.
[51]   | Kennedy, D.O., Haskell, C.F., Wesnes, K.A. and Scholey, A.B. “Improved cognitive performance in human volunteers following administration of guarana (Paullinia cupana) extract: comparison and interaction with Panax ginseng”, Pharmacology, Biochemistry and Bahavior, 79(3). 401-411. 2004.
[52]   | Santa Maria, A., Lopez, A., Diaz, M.M., Munoz-Mingarro, D. and Pozuelo, J.M., “Evaluation of the toxicity of guaraná with in vitro bioassays”, Ecotoxicology and environmental safety, 39(3). 164-167. 1998.

[53]  
Bittencourt, L.S., Machado, D.C., Machado, M.M., Dos Santos, G.F.F., Algarve, T.D., Marinowic, D.R., Ribeiro, E.E., Soares, F.A.A., Barbisan, F., Athaíde, M.L. and Cruz, I.B.M., “The protective effects of guaraná extract (Paullinia cupana) on fibroblast NIH-3T3 cells exposed to sodium nitroprusside”, Food and Chemical Toxicology, 53.119-125. 2013.

[54]   | Salunkhe, D.K., Chavan, J.K. and Kadam, S.S. Dietary tannins: consequences and remedies, Boca Raton: CRC Press, 1990. 200p.
[55]   | Sgarbieri, V.C. Proteínas em alimentos protéicos: propriedades - degradações - modificações. Cap. 5: Deterioração e modificações químicas, físicas e enzimáticas de proteínas. São Paulo: Varela; 1996.
[56]   | Deshpande, S.S., Cheryan, M. and Salunkhe, D.K., “Tannin analysis of food products”, CRC Critical Reviews in Food Science and Nutrition, 24(4). 401-449. 1986.
[57]   | Singleton, V.L., “Naturally occurring food toxicants: phenolic substances of plant origin common in food”, Advances in Food Research, 27.149-242. 1981.
[58]   | Salunkhe, D.K., Jadhav, S.J., Kadam, S.S. and Chavan, J.K., “Chemical, biochemical, and biological significance of polyphenols in cereals and legumes”, CRC Critical Reviews in Food Science and Nutrition, 17(3). 277-305. 1982.
[59]   | Bartolomé, B., Jiménez- Ramsey, L.M. and Butler, L.G., “Nature of the condensed tannins present in the dietary fibre fractions in foods”, Food Chemistry, 53(4). 357-362. 1995.
[60]   | Rao, B.S.N. and Prabhavathi, T., “Tannin content of foods commonly consumed in India and its influence on ionisable iron”, Journal of the Science of Food Agriculture, 33(1). 89-96.1982.

[61]  
Siegenberg, D., Baynes, R.D., Bothwell, T.H., Macfarlane, B.J., Lamparelli, R.D., Car, N.G., McPhail, P., Schmitd, U., Tal, A. and Mayet, F., “Ascorbic acid prevents the dose-dependent inhibitory effects of polyphenols and phytates on nonheme-iron absorption”, American Journal of Clinical Nutrition, 53. 537-541.1991.

[62]   | Proulx, W.R., Weaver, C.M. and Bock, M.A. “Trypsin inhibitor activity and tannin content do not affect calcium bioavaliability of three commonly consumed legumes”, Journal of Food Science, 58(2). 382-384.1993.
[63]   | Heaney, R.P., “Effects of caffeine on bone and calcium economy”, Food Chem. Toxicol, 40: 1263-1270.2002.
[64]   | Nawrot, P., Jordan, S., Eastwood, J., Rotstein, J., Hugenholtz, A. and Feeley, M., “Effects of caffeine on human health”, Food Addit Contam, 20(1).1-30.2003.
[65]   | De Maria, C.A.B. and Moreira, R.F.A., “Cafeína: revisão sobre métodos de análise”, Quim Nova, 30(1). 99-105. 2007.

[66]  
Anvisa. Agência Nacional de Vigilância Sanitária. Instrução Normativa n. 05/2008. Dispõe sobre o Lista de Medicamentos Fitoterápicos de Registro Simplificado. Brasília (Brasil): Ministério da Saúde 2008. Available: http://189.28.128.100/dab/docs/legislacao/instrucao05_11_12_08.pdf. [Accessed April 02, 2018].

[67]  
Ogava, S.E.M., Pinto, M.T.C., Kikuchi, T., Menegueti, V.A.F., Martins, D.B.C., Coelho, S.A.D., Marques, M.J.N.J.; Virmond, J.C.S.; Monteschio, P., D'Aquino, M. and Marques, L.C., “Implantação do programa de fototerapia “Verde Vida” na secretaria de saúde de Maringá (2000-2003)”, Revista Brasileira de Farmagnosia, 13(suppl.1). 58-62. 2003.

[68]   | Nicoletti, M.A., Oliveira-Junior, M.A., Bertasso, C.C., Coporossi, T.Y. and Tavares, A.P.L., “Principais interações no uso de medicamentos fitoterápicos”, Infarma, 19(1/2). 32-40. 2007.
[69]   | Gonçalves, N.M.T., Gerenutti, M., Chaves, D.S.A., Vila and M.M.D.C., “The folk tradition as a tool for the deployment of phytotherapy in the city of Volta Redonda – RJ”, Rev. Bras. Farm. 92(4). 346-351. 2011.
[70]   | Freitas, R.S., Moreno, S.R.F., Lima-Filho, G.L., Fonseca, A.S. and Bernardo-Filho, M., “Effect of a commercial extract of Paullinia cupana (guarana) on the binding of 99mTc-DMSA on blood constituents: An in vivo study”, Applied Radiation and Isotopes, 65(5). 528-533. 2007.
[71]   | Kuri, C.M.B., “The guarana industry in Brazil”, International Business and Economics Research Journal, 7. 87-98. 2008.
[72]   | Futuro, D.O., Fiorini, F.S. and Castilho, S.R., “Interações entre Plantas e Medicamentos”, Informativo CEATRIM, 2004. Available: http://www.crf-rj.org.br/crf/infor/cetrim/arquivos/200412_CEATRIM.pdf. [Accessed April 10, 2018].
[73]   | Izzo, A.A. and Ernst, E., “Interactions between herbal medicines and prescribed drugs: A systematic review”, Drugs, 61(15).2163-2175.2001.
[74]   | Veiga Junior, V.F., Pinto, A.C. and Maciel, M.A.M., “Plantas medicinais: cura segura?”, Química Nova. 28(3).519-528.2005.
[75]   | Anvisa. Agência Nacional de Vigilância Sanitária. Farmacopéia Brasileira. 5. ed. Brasília: Ministério da Saúde, 1.524.2010. Available: http://www.anvisa.gov.br/hotsite/cd_farmacopeia/pdf/volume1.pdf. [Accessed May 25, 2018].
[76]   | Brito, R.S. “O guaraná”, Agric e Pec, 2(42). 619-21.1930.
[77]   | Barretto, L.P., “O Guaraná: a planta e suas virtudes, utilização e exportação”, O Campo, 103.45-50. 1938.
[78]   | Watzel, J., “O guaraná, seu valor industrial e medicinal”, Boletim do Ministério de Agricultura, 26(416). 25-32. 1937.
[79]   | Machado, O., “Contribuição ao estudo das plantas medicinais do Brasil: O Guaraná”, Rodriguesia. 20(9). 89-110. 1946.
[80]   | Castro, J.B. de A.A., “A cultura do guaraná na Bahia”, Suplemento Agrícola de O Estado de São Paulo, 20(999). 8-10. 1974.
[81]   | Carlini, E. A., “Plants and the central nervous system”, Pharmacology, Biochemistry and Behavior, 75(3).501-512.2003.
[82]   | Sporn, M.B. and Suh, N., “Chemoprevention: uma abordagem essencial para controlar o câncer”, Nat Rev Cancer, 2(7). 537-543. 2002.
[83]   | Yang, H., Rouse, J., Lukes, L., Lancaster, M., Veenstra, T., Zhou, M., Shi, Y., Yeong-Gwan, P., Hunter, K., “Caffeine suppresses metastasis in a transgenic mouse model: a prototype molecule for prophylaxis of metastasis”, Clin Exp Metastasis, 21(8). 719-735. 2005.
[84]   | Firmo, W.C.A., Menezes, V.J.M., Passos, C.E.C., Dias, C.N., Alves, L.P.L., Dias, I.C.L., Neto, M.S. and Olea, R.S.G., “Historical context, popular use and scientific conception on medicinal plants”, Cad Pesq, 18. 90-94. 2011.
[85]   | Klein, T., Longhini, R., Bruschi, M.L. and Mello, J.C.P., “Fitoterápicos: um mercado promissor”, J Basic Appl Pharm Sci, 30. 241-248. 2009.
[86]   | Andrade, L., Schenkel, E.P. and Bergold, A.M., “Estudo da metodologia de análise de cafeína em sementes de guaraná (Paullinia cupana)”, Rev Bras Farm, 80. 7-9. 1999.
[87]   | Simões, C.L.O., Schenkel, E.P., Gosmann, G., Mello J.C.P., Mentz, L.A. and Petrovick, P.R., Farmacognosia: da Planta ao Medicamento, 5. ed. Porto Alegre, Editora UFRGS; Florianópolis: UFSC, 821. 2003.
[88]   | Santos, S.C. and Mello, J.C.P., Taninos. In: Simões CMO (org.). Farmacognosia da planta ao medicamento. 5. ed. Porto Alegre: Editora da Universidade Federal do Rio Grande do Sul, 615-656. 2007.
[89]   | Subbiah, M.T. and Yunker, R., “Studies on the nature of anti-platelet aggregatory factors in the seeds of the Amazonian Herb Guarana (Paullinia cupana)”, International Journal for Vitamin and Nutrition Research, 78. 96-101, 2008.
[90]   | Gnoatto, S.C.B., Bassani, V.L., Coelho, G.C. and Schenkel, E.P., “Influência do método de extração nos teores de metilxantinas em erva-mate (Ilex paraguariensis a. st.-hil., aquifoliaceae)”, Química nova, 30(2). 304-307. 2007.